Skip to content

Sigh Ventilation on Postoperative Hypoxemia in Cardiac Surgery

Effect of Perioperative Sigh Ventilation on Postoperative Hypoxemia and Pulmonary Complications After On-pump Cardiac Surgery: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06248320
Enrollment
192
Registered
2024-02-08
Start date
2024-02-25
Completion date
2024-08-11
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lung Injury, Cardiac Disease, Hypoxemia, Postoperative Complications

Keywords

Mechanical ventilation, Cardiac Surgery, Hypoxemia, Pulmonary Complications

Brief summary

Postoperative pulmonary complications (PPCs) remain a frequent event after pump-on cardiac surgery and are mostly characterized by postoperative hypoxemia.These complications are significant contributors to prolonged intensive care unit admissions and an escalation in in-hospital mortality rates. The dual impact of general anesthesia with invasive mechanical ventilation results in ventilator-induced lung injury, while cardiac surgery introduces additional pulmonary insults. These include systemic inflammatory responses initiated by cardiopulmonary bypass and ischemic lung damage consequent to aortic cross-clamping. Contributing factors such as blood transfusions and postoperative pain further exacerbate the incidence of PPCs by increasing the permeability of the alveolar-capillary barrier and disrupting mucociliary functions, often culminating in pulmonary atelectasis. Protective ventilation strategies, inspired by acute respiratory distress syndrome (ARDS) management protocols, involve the utilization of low tidal volumes (6-8mL/kg predicted body weight). However, the uniform application of low tidal volumes, especially when combined with the multifactorial pulmonary insults inherent to cardiac surgery, can precipitate surfactant dysfunction and induce atelectasis. The role of pulmonary surfactant in maintaining alveolar stability is critical, necessitating continuous synthesis to sustain low surface tension and prevent alveolar collapse. The most potent stimulus for surfactant secretion is identified as the mechanical stretch of type II pneumocytes, typically induced by larger tidal volumes. This background sets the foundation for a research study aimed at assessing the safety and efficacy of incorporating sighs into perioperative protective ventilation. This approach is hypothesized to mitigate postoperative hypoxemia and reduce the incidence of PPCs in patients undergoing scheduled on-pump cardiac surgery.

Detailed description

The purpose of this single center, parallel group, randomized controlled study is to evaluate the effect of a perioperative sigh ventilation strategy on postoperative outcomes during the first 7 days following cardiac surgery. The study will include 192 adult patients undergoing scheduled on-pump cardiac surgery. The sigh ventilation approach will combine sigh ventilation and lung protective ventilation (6-8 ml/kg/pbw) from intubation to extubation. It will be compared to a conventional approach without sigh ventilation, with lung protective ventilation and positive end-expiratory pressure (PEEP) setting same as the intervention arm. The primary endpoint is the Spo2/Fio2 ratio during the initial post extubation hour. The secondary endpoints are postoperative pulmonary complications and hospital length of stay .

Interventions

PROCEDURESigh ventilation

Sigh breaths were delivered from intubation to extubation. Intervention primarily conducted in the following three stages: 1. From intubation to surgical opening of the chest cavity; 2. From the surgical closure of the chest cavity close and continue unit the operating room exiting; 3. From Intensive Care Unit (ICU) arrival to Spontaneous breathing trial (SBT) start.

Sponsors

Zhongda Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elective cardiac surgery with general anesthesia * Conventional cardiopulmonary bypass and aortic cross clamp * Providing written informed consent by the patient himself/herself or the next of kin

Exclusion criteria

* Emergent surgery including aortic dissection, cardiac rupture and active endocarditis surgery * Left ventricular assist device implantation * Patients anticipated to require intraoperative support with Extracorporeal Membrane Oxygenation (ECMO) or Intra-Aortic Balloon Pump (IABP) * Chronic pulmonary disease requiring long-term home oxygen therapy * Receiving invasive mechanical ventilation within 7 days prior to surgery * Preoperative shock * Obstructive Sleep Apnea Syndrome (OSAS) requiring intermittent non-invasive ventilatort support * Preoperative left ventricular ejection fraction\<40% * Pulmonary arterial systolic pressure\>50 mmHg * Redo surgery

Design outcomes

Primary

MeasureTime frameDescription
Time-weighted average pulse oximetry (SpO2/FiO2)1 hour after endotracheal extubationCalculated the SpO2/FiO2 ratio every 15min during the initial postextubation hour, then averaged the SpO2/FiO2 ratios weighted by measurement interval. The comparison between arms was made through T-test.

Secondary

MeasureTime frameDescription
Proportion of respiratory failurefirst 7 days postextubationMild respiratory failure: SpO2 \< 90% or PaO2 \< 60 mmHg after breathing ambient air for 10 min (excluding hypoventilation) and corrected with an oxygen supply of 1-3 L/min with a nasal cannula; Moderate respiratory failure: SpO2 \< 90% or PaO2 \< 60 mmHg despite a 3 L/min oxygen supply with a nasal cannula (excluding hypoventilation) and corrected with an oxygen supply from 4 to 10 L/ min with a face mask; Severe respiratory failure: SpO2 \< 90% or PaO2 \< 60 mmHg despite a 10 L/min oxygen supply with a face mask (excluding hypoventilation) and corrected with an oxygen supply \> 10 L/min with a high-flow face mask or with non-invasive ventilation or with high-flow nasal oxygen therapy or with invasive mechanical ventilation. Using the worst score in the first 7 days postextubation for main analysis. Tested between arms through ordinal logistic regression.
Severity of postoperative pulmonary complicationsfirst 7 days after surgeryScore of pulmonary complications adapted from previous publications, with 5 degrees, where the higher one means death before hospital discharge, degree (4) means the need of mechanical ventilation for more than 48 hours after surgery or after reintubation, degree (3) means pneumonia or intense noninvasive ventilation need, degree (2) means hypoxemia and abnormal lung findings, degree 1 means simple atelectasis and degree (0) means no complication. Using the worst score in the first 7 days after surgery for main analysis. Tested between arms through ordinal logistic regression.
Invasive mechanical ventilation (IMV) daysfirst 7 days after surgeryDurations of invasive mechanical ventilation.
Reintubation ratefirst 7 days after surgeryOccurrence of endotracheal reintubation.
Proportion of receiving non-invasive ventilation (NIV) or High-flow nasal cannula (HFNC) supportfirst 7 days after surgeryTested through the Fisher exact test or chi-square test.
No ventilatory-support daysfirst 7 days after surgeryDays alive and not receive IMV, HFNC and non-invasive ventilatory support.
In-hospital mortalityFrom the day of surgery up to Hospital discharge or death, maximum censoring at day 28 after surgeryDeaths occurred during hospital stay
Length of ICU stayFrom the day of surgery up to ICU discharge, maximum censoring at day 28 after surgeryDays since surgery until ICU discharge
Length of hospital stayFrom the day of surgery up to Hospital discharge, maximum censoring at day 28 after surgeryDays since surgery until Hospital discharge

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026